Genzyme Sues Over Endo's Bid To Sell Generic Renvela

By Erin Marie Daly · April 27, 2011, 8:24 PM EDT

Genzyme Corp. on Wednesday filed suit in Maryland accusing Endo Pharmaceuticals Inc. of infringing its patent covering Renvela by seeking approval to sell a generic version of the kidney disease treatment...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Genzyme Corporation v. Endo Pharmaceuticals Inc.

Case Number

1:11-cv-01103

Court

Maryland

Nature of Suit

Patent

Date Filed

April 27, 2011